The effect of L-carnitin as an adjunctive therapy in treatment of negative and positive symptom in schizophrenia
Phase 3
Recruiting
- Conditions
- Schizophrenia.Schizophrenia
- Registration Number
- IRCT20191218045795N6
- Lead Sponsor
- Sanandaj University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not having severe major depression based on Beck Depression Test (BECK Total score<29
have received psychiatric drugs with a fixed dose during the last 3 months.
be treated with one of the second generation antipsychotic drugs
Exclusion Criteria
Presence of another diagnosis based on DSM-5
Intellectual disability
Received ECT in the past 2 months
History of substance and drug use except nicotine and caffeine
History of seizures
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method